Fibromyalgia Acupuncture Study

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Sivarama Vinjamury, Southern California University of Health Sciences
ClinicalTrials.gov Identifier:
NCT00882271
First received: April 14, 2009
Last updated: November 16, 2011
Last verified: November 2011

April 14, 2009
November 16, 2011
January 2008
November 2011   (final data collection date for primary outcome measure)
  • Health/Activity Questionnaire [ Time Frame: Baseline ] [ Designated as safety issue: No ]
  • The Fibromyalgia Impact Questionnaire [ Time Frame: Baseline and end of 5th, 10th treatments and end of 1, 2, 3, 4, 5, and 6 months ] [ Designated as safety issue: No ]
  • Multidimensional Pain Inventory [ Time Frame: Baseline and end of 5th, 10th treatments and end of 1, 2, 3, 4, 5, and 6 months ] [ Designated as safety issue: No ]
  • Beck Depression Inventory [ Time Frame: Baseline and end of 5th, 10th treatments and end of 1, 2, 3, 4, 5, and 6 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00882271 on ClinicalTrials.gov Archive Site
30-sec Chair Stand [ Time Frame: Baseline and end of 5th, 10th treatments and end of 1, 2, 3, 4, 5, and 6 months ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Fibromyalgia Acupuncture Study
Efficacy of Acupuncture to Improve Symptoms and Functionality for People With Fibromyalgia

The acupuncture treatment in this study is particularly aimed at reducing the pain and other negative health events such as emotional trauma and disability associated with Fibromyalgia, while improving the quality of life and promoting general health.

It is hypothesized that acupuncture treatment will be effective in reducing pain and improving lower body strength and overall functionality more than the sham acupuncture treatment in people with Fibromyalgia (FM). The purpose of this study is to compare the efficacy of acupuncture with simulated acupuncture in patients with FM using a randomized controlled design. More specifically, the objectives of this study are to determine if acupuncture can (1) reduce pain, (2) improve lower body strength, and (3) improve overall functionality.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Fibromyalgia
Other: Acupuncture
Ten Acupuncture treatments within six weeks
  • Experimental: 1
    Traditional Chinese Acupuncture
    Intervention: Other: Acupuncture
  • Placebo Comparator: 2
    Placebo Acupuncture
    Intervention: Other: Acupuncture
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
50
November 2011
November 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  1. Participants must be 18 years or older and can be of either sex.
  2. A confirmed diagnosis of FM (pain for more than three months) will be required to participate in the study. If they do not have a diagnosis the study clinician or research assistant will examine them and determine their eligibility.
  3. All participants must be willing to provide a written informed consent prior to participation and should not have undergone acupuncture treatment in the past.

Exclusion Criteria:

  1. Acupuncture treatment in the past five years.
  2. Unwilling to sign informed consent.
  3. Less than a score of 40 on the Fibromyalgia Impact Questionnaire,
  4. Involvement in any litigation currently or in the past,
  5. Simultaneous infection with HIV/Hepatitis B virus.
  6. Severe depression (Beck depression score >21),
  7. History of substance abuse or dependence within the past year, excluding nicotine and caffeine.
  8. Serious or unstable cardiovascular, hepatic, renal, respiratory, or hematologic illness, symptomatic peripheral vascular disease, or other medical conditions (including unstable hypertension, hypo or hyperthyroidism, or psychological conditions that in the opinion of the investigators would compromise participation or be likely to lead to an adverse response, including injuries or hospitalization, during the course of the study. We will get the information from the health/activity questionnaire.
  9. Have any DSM-IV Axis (major depression, addiction, anxiety) disorder which, in the judgment of the investigators, would interfere with compliance with the study protocol.
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00882271
SCU-08-VINJ003
Yes
Sivarama Vinjamury, Southern California University of Health Sciences
Southern California University of Health Sciences
Not Provided
Principal Investigator: Sivarama P Vinjamury, MD, MAOM Southern California University of Health Sciences
Southern California University of Health Sciences
November 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP